BIOMAT Database Logo BIOMAT Database Logo

DNA topoisomerase I inhibitors from Rinorea anguifera. 2005

Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
Department of Chemistry and Department of Biology, University of Virginia, Charlottesville, VA 22901, USA.

An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.

UI MeSH Term Description Entries
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans

Related Publications

Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
DNA topoisomerase I inhibitors.
January 1997, Cancer chemotherapy and biological response modifiers,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
DNA topoisomerase I inhibitors: cytotoxic flavones from Lethedon tannaensis.
July 1996, Journal of natural products,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
Small DNA circles as bacterial topoisomerase I inhibitors.
June 2019, RSC advances,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
Synthetic inhibitors of DNA topoisomerase I and II.
January 1999, Chemical & pharmaceutical bulletin,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
Natural inhibitors of DNA topoisomerase I with cytotoxicities.
July 2008, Chemistry & biodiversity,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
[Topoisomerase I inhibitors].
May 1997, Medizinische Monatsschrift fur Pharmazeuten,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
Topoisomerase I Inhibitors.
January 1997, The oncologist,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
DNA topoisomerase inhibitors.
January 1994, Cancer chemotherapy and biological response modifiers,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
DNA topoisomerase inhibitors.
January 1996, Cancer chemotherapy and biological response modifiers,
Ji Ma, and Shannon H Jones, and Rebekah Marshall, and Xihan Wu, and Sidney M Hecht
DNA-topoisomerase inhibitors.
November 1993, Current opinion in oncology,
Copied contents to your clipboard!